Sameeksha PMS

PMS

IME's View on Sameeksha PMS

AMC View

Sameeksha Capital's credibility is based on founder Bhavin Shah's extensive experience as a top-rated senior analyst at JP Morgan & Credit Suisse, and as head of Equirius Research. With a focus on fundamental research and proprietary tools, Sameeksha Capital is a strong boutique option among PMS firms.

AMC Pedigree

Sameeksha Capital's strong pedigree is founded on founder Bhavin Shah's expertise in fundamental research. The firm has developed robust institutional research processes and proprietary tools to enhance their research capabilities.

Team Pedigree

Bhavin Shah brings a distinguished track record in equity research, having been a top-ranked institutional Asia-Pacific technology analyst at both Credit Suisse and JP Morgan. He also played a pivotal role in building Equirus Securities from the ground up before founding Sameeksha Capital. Known for his strong research pedigree, Bhavin brings deep fundamental research principles and philosophies to Sameeksha’s investment approach.

Investment Philosophy

Sameeksa Capital uses a rigorous fundamental research process, based on Bhavin's extensive experience as a top-rated equity analyst, to identify appealing investment opportunities. They are fairly dynamic in their approach - taking active cash calls & rotating across market capitalisation based on their market view (for example smallcap exposures have moved from as high as 60% in CY23-24 to sub 30% in CY21-22, & they have taken 20%+ cash calls a few times in the past).

AMC Background

Sameeksha Capital was founded in 2015 by Bhavin Shah, a highly acclaimed equity and technology analyst, initially as a vehicle to manage his personal capital within a structured framework before being opened to external investors via a PMS platform. The AMC’s pedigree is closely tied to Bhavin Shah’s strong fundamental research credentials, particularly in the technology sector, where he has received multiple industry awards. This deep research background has shaped Sameeksha’s identity as a research-led PMS with a strong emphasis on process, discipline, and bottom-up stock selection.

Investment Philosophy

Sameeksha’s investment philosophy is anchored in Bhavin Shah’s time-tested fundamental research approach, which has been institutionalised into robust internal processes and proprietary frameworks. The philosophy focuses on combining business quality with valuation discipline, actively managing downside risks, and continuously reassessing investment merit as prices evolve.

Core Pillars of the Philosophy

  • Proprietary Multi-layered Stock Selection Checklist: A structured process designed to eliminate weak business models while reducing behavioural and personal biases.
  • Value vs Quality Matrix: A proprietary framework that ensures high-quality businesses are purchased with valuation discipline.
  • Active Sell Framework: Continuous reassessment of holdings as stocks approach forward intrinsic value, ensuring capital is redeployed efficiently.
  • Detailed Financial Models: Standardised, in-house earnings models that provide granular insights into both business quality and valuation.

Risk Management

  • Sectoral Exposure: Capped at <40% to limit concentration risk.
  • Loss Minimisation: Mandatory review of positions that decline ~15%, conducted under normal market conditions to distinguish stock-specific issues from broader market volatility.

Portfolio Construction

Sameeksha follows a flexible, bottom-up portfolio construction approach centred on conviction rather than model portfolios. Portfolios are tailored based on prevailing opportunities at the time of investment, with active use of cash and selective hedging when appropriate.

  • Concentration: Typically 15–30 stocks, with larger weights in high-conviction ideas.
  • Cash & Hedging: Ability to hold cash and partially hedge using index futures (subject to client mandate).
  • Investment Horizon: >2 years, with periodic review of all positions.
  • Position Limits: Maximum 20% at cost and no more than 30% at market value.
  • Execution Flexibility: No rigid model portfolio; only stocks trading below buy levels are added to new client accounts.

Suitable For

Investors seeking a concentrated, research-driven PMS strategy backed by strong fundamental analysis, active portfolio management, and disciplined downside risk controls.

Investment team

Bhavin Shah | 4-star rated FM

Founder & Fund Manager | 29 yrs Experience | 10 yrs at current firm

Past Experience: Equirius Securities (Founder & CEO), JP Morgan (Head-Asia Pac Tech Research), Credit Suisse (Head-Asia Pac Tech Research)

Bhavin Shah comes with impeccable research credentials, especially in the technology space where he has repeatedly been a top-ranked analyst by Global Institutional Investors. He has also been responsible for building up 3 institutional equity franchises - at Equiris and the technology desks for JP Morgan & Credit Suisse.

Recommended Funds

Sameeksha Equity Fund AIF

1 Year
10%
3 Year
29.6%
5 Year
-

Sameeksha Equity

1 Year
6.6%
3 Year
25.7%
5 Year
25.8%

Experience the benefits of working with a 'research-first' investments firm

Free 30-Day Trial

Get complimentary access to the revolutionary IME RMS (direct access to IME's central team insights across 1000's of MFs, PMSs, AIFs & Global funds - a first in the industry).

Additionally, a dedicated private banker will help build your financial plan, investment mandate & undertake a comprehensive portfolio review for free.

IME RMS - Preview

IME Capital Logo

IME Capital is a research-first investments firm. We aim to disrupt the wealth management industry, by shrinking the gap in investment insights between central research teams & RMs/Clients.

Disclaimer MF/PMS/AIF/Direct Equities are all subject to market risks. Please read the scheme information and other related documents carefully prior to investing. Past performance is not indicative of future returns. Please consider your specific investment requirements before choosing a fund or designing a portfolio that suits your needs. Market & other data on this site has been sourced from what are considered to be reliable sources. All views shared (product ratings, views on individual securities etc.) are the proprietary property of IME Capital and cannot be used in any form without explicit written consent. IME Capital Pvt. Ltd. makes no warranties or representations, express or implied, on products offered through the platform (and that of our partners) or on the correctness of data & views shared. It accepts no liability for any damages or losses, however caused, in connection with the use of, or on the reliance of its product or related services. Detailed Disclaimer | © 2021 All rights reserved | ARN No: ARN-182445